2025年新型药物输送系统全球市场报告

新型药物输送系统市场预计将在未来几年强劲成长，到 2029 年将达到 1,710.2 亿美元，年复合成长率（CAGR）为 9.8%。预测期内的成长可以归因于以下因素：全球对疫情预防的关注度不断提高、对快速和有针对性的药物输送的需求不断增长、抗菌素管理意识的不断提高、更严格的环境和包装法规有利于控制输送方法，以及医药创新领域官民合作关係的不断加强。这段时期的主要趋势包括奈米载体和乳化的应用、可生物降解和刺激响应材料的开发、3D 列印在个人化剂型中的应用日益广泛、经皮和微针技术的进步以及人工智慧在製剂设计中的应用。

神经系统疾病发生率的不断上升预计将推动新型药物传输系统市场的成长。中风等神经系统疾病是指因脑血流受阻（缺血性中风）或血管破裂（出血性中风）而导致神经功能突然丧失，从而造成脑损伤以及认知、感觉和运动方面的长期障碍。人口老化、高血压、糖尿病和肥胖等文明病的增加以及慢性压力和环境风险的增加等因素导致了神经病变的增加。新型药物输送系统可以透过跨血脑障壁提供标靶化和可控的药物输送来帮助治疗这些疾病。例如，2024 年 11 月，英国国家医疗服务体系 (NHS) 报告称，2023/24 年英国住院中风患者人数将达到 111,137 人，其中 50-59 岁年龄组增幅最大，将新增 12,533 例。因此，神经系统疾病的盛行率不断上升，刺激了新型药物传输系统市场的发展。

新型药物输送系统市场的主要企业正在透过口腔薄膜等产品进行创新，以提高患者的依从性和治疗效果。口腔薄膜是一种即溶贴片，贴于口腔，可将药物透过黏膜直接输送到血液中。例如，2024年2月，美国製药製剂公司CD Formulation推出了其口腔薄膜技术。该技术可绕过胃肠道和肝臟代谢，实现药物的快速吸收，是吞嚥困难患者的理想选择。此外，该技术还能达到精准给药和快速起效，进而提高多种治疗的精准度和便利性。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

• 全球新型药物输送系统：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
• 最终用途产业分析
• 全球新型药物输送系统市场：成长率分析
• 全球新型药物输送系统市场表现：规模与成长，2019-2024
• 全球新型药物输送系统市场预测：规模与成长，2024-2029 年，2034 年
• 全球新型药物输送系统：总目标市场（TAM）

第六章市场区隔

• 全球新型药物输送系统市场（按製剂类型、实际及预测），2019-2024 年、2024-2029 年、2034 年
• 脂质体
• 奈米粒子
• 微球
• 水凝胶
• 树状聚合物
• 全球新型药物输送系统市场：新型药物输送系统 (NDDS) 的模式、实际和预测，2019-2024 年、2024-2029 年、2034 年
• 标靶药物传输系统
• 受管制药物传输系统
• 受管制药物传输系统
• 全球新型药物输送系统市场：按途径、实际状况及预测，2019-2024 年、2024-2029 年、2034 年
• 口服给药系统
• 注射药物输送系统
• 肺部给药系统
• 经皮药物输送系统
• 其他路线
• 全球新型药物输送系统市场：依治疗领域、实际及预测，2019-2024 年、2024-2029 年、2034 年
• 癌症
• 心血管疾病
• 神经系统疾病
• 感染疾病
• 自体免疫疾病
• 全球新型药物输送系统市场：依最终用户、实际及预测，2019-2024 年、2024-2029 年、2034 年
• 医院
• 专科诊所
• 研究中心
• 其他最终用户
• 全球新型药物传输系统市场：脂质体细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 聚乙二醇化脂质体
• 阳离子脂质体
• 隐形脂质体
• 免疫脂质体
• 全球新型药物传输系统市场：按奈米颗粒类型、性能和预测细分，2019-2024 年、2024-2029 年、2034 年
• 聚合物奈米粒子
• 脂质奈米颗粒
• 金属奈米粒子
• 奈米晶体
• 全球新型药物输送系统市场：按微球类型细分、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 可生物降解微球
• 磁性微球
• 放射性微球
• 黏膜黏附微球
• 全球新型药物传输系统市场：水凝胶细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 温敏水凝胶
• pH响应性水凝胶
• 可注射水凝胶
• 智能水凝胶
• 全球新型药物输送系统市场：依树状聚合物类型细分、实际结果及预测（2019-2024 年、2024-2029 年及 2034 年）
• PAMAM树状聚合物
• PPI树状聚合物
• 聚乙二醇化树状聚合物
• 混合树状聚合物

第七章 区域和国家分析

• 全球新型药物输送系统市场：按地区、结果和预测，2019-2024 年、2024-2029 年、2034 年
• 全球新型药物输送系统市场：依国家、实际结果及预测（2019-2024 年、2024-2029 年、2034 年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第十八章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

• 新型药物输送系统市场：竞争格局
• 新型药物输送系统市场：公司简介
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

• Bayer AG
• Sanofi SA
• Bristol-Myers Squibb Company
• Thermo Fisher Scientific Company
• AstraZeneca PLC
• Abbott Laboratories
• Novartis AG
• GlaxoSmithKline PLC（GSK）
• Takeda Pharmaceutical Company Limited
• Eli Lilly and Company
• Gilead Sciences
• Amgen Inc.
• Teva Pharmaceutical Industries Ltd.
• Otsuka Pharmaceutical Co. Ltd.
• Boston Scientific Corporation

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

• 2029年新型药物输送系统市场：提供新机会的国家
• 2029年新型药物输送系统市场：提供新机会的细分市场
• 2029年新型药物输送系统市场：成长策略
  • 基于市场趋势的策略
  • 竞争对手的策略

第36章 附录

Novel drug delivery systems are advanced pharmaceutical technologies aimed at improving the effectiveness, safety, bioavailability, and targeted delivery of medications by precisely controlling the rate, timing, and location of drug release in the body. These systems address the shortcomings of traditional delivery methods, enhance treatment outcomes, and boost patient adherence across diverse medical and therapeutic fields.

Key formulation types within novel drug delivery systems include liposomes, nanoparticles, microspheres, hydrogels, and dendrimers. Liposomes are spherical vesicles made of phospholipid bilayers that encapsulate drugs, allowing for targeted delivery, controlled release, and minimized drug toxicity. The delivery modes include targeted, controlled, and modulated drug delivery systems, which are administered through various routes such as oral, injectable, pulmonary, transdermal, and others. These systems are applied in multiple therapeutic areas including cancer, cardiovascular diseases, neurological disorders, infectious diseases, and autoimmune diseases, serving end-users like hospitals, specialty clinics, research centers, and more.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The novel drug delivery systems market research report is one of a series of new reports from The Business Research Company that provides novel drug delivery systems market statistics, including novel drug delivery systems industry global market size, regional shares, competitors with a novel drug delivery systems market share, detailed novel drug delivery systems market segments, market trends and opportunities, and any further data you may need to thrive in the novel drug delivery systems industry. This novel drug delivery systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The novel drug delivery systems market size has grown rapidly in recent years. It will grow from $106.95 billion in 2024 to $117.66 billion in 2025 at a compound annual growth rate (CAGR) of 10.0%. The growth during the historic period can be linked to the increasing prevalence of chronic diseases, an expanding geriatric population, rising demand for minimally invasive treatments, heightened patient awareness about drug efficacy and safety, and the development of global healthcare infrastructure.

The novel drug delivery systems market size is expected to see strong growth in the next few years. It will grow to $171.02 billion in 2029 at a compound annual growth rate (CAGR) of 9.8%. The growth projected for the forecast period can be attributed to a heightened global emphasis on pandemic preparedness, increased demand for rapid and targeted drug delivery, greater awareness of antimicrobial stewardship, stricter environmental and packaging regulations favoring controlled delivery methods, and expanding public-private partnerships in pharmaceutical innovation. Key trends during this period include the incorporation of nanocarriers and nanoemulsions, development of biodegradable and stimuli-responsive materials, wider use of 3D printing for personalized dosage forms, advancements in transdermal and microneedle technologies, and the adoption of artificial intelligence in formulation design.

The increasing cases of neurological disorders are anticipated to drive growth in the novel drug delivery systems market. Neurological disorders like stroke involve the sudden loss of neurological function caused by interrupted blood flow to the brain, either through a blockage (ischemic stroke) or a blood vessel rupture (hemorrhagic stroke), resulting in brain damage and possible long-term impairments in cognition, sensation, or movement. Factors such as aging populations, the rising prevalence of lifestyle-related conditions including hypertension, diabetes, and obesity, as well as greater exposure to chronic stress and environmental risks, are contributing to the increase in neurological disorders. Novel drug delivery systems aid in treating these disorders by providing targeted and controlled delivery of medications across the blood-brain barrier. For example, in November 2024, the National Health Service (NHS) England reported that stroke admissions in England reached 111,137 in 2023/24, with the highest rise seen in the 50-59 age group, which had 12,533 new cases. Consequently, the growing incidence of neurological disorders is fueling the novel drug delivery systems market.

Leading companies in the novel drug delivery systems market are innovating with products like oral thin films to improve patient compliance and treatment effectiveness. Oral thin films are rapidly dissolving strips applied inside the mouth that deliver drugs directly into the bloodstream through the mucosal lining. For example, in February 2024, CD Formulation, a US pharmaceutical formulation company, introduced Oral Thin Film Technology. This technology enables quick drug absorption by bypassing the gastrointestinal tract and liver metabolism, making it ideal for patients who have difficulty swallowing. It also allows precise dosing and faster onset of effects, enhancing treatment accuracy and convenience across multiple therapies.

In April 2023, DifGen Pharmaceuticals LLC, a US-based pharmaceutical firm, acquired Aveva Drug Delivery Services Inc. for an undisclosed sum. This acquisition is intended to expand DifGen's expertise in complex dosage forms by adding US research and manufacturing capabilities for transdermal and thin film drug delivery systems. Aveva Drug Delivery Services Inc. specializes in transdermal drug delivery and oral dissolvable films.

Major players in the novel drug delivery systems market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi SA, Bristol-Myers Squibb Company, Thermo Fisher Scientific Company, AstraZeneca PLC, Abbott Laboratories, Novartis AG, GlaxoSmithKline PLC (GSK), Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences, Amgen Inc., Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Boston Scientific Corporation, Regeneron Pharmaceuticals, Samyang Holdings Corporation, and Galen Limited.

North America was the largest region in the novel drug delivery systems market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in novel drug delivery systems report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the novel drug delivery systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The novel drug delivery systems market consists of sales of implants, micelles, exosomes, prodrugs, nasal drug delivery devices, buccal drug delivery films, and ocular drug delivery inserts. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Novel Drug Delivery Systems Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on novel drug delivery systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for novel drug delivery systems ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The novel drug delivery systems market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Formulation Type: Liposomes; Nanoparticles; Microspheres; Hydrogels; Dendrimers
• 2) By Mode Of Novel Drug Delivery System (NDDS): Targeted Drug Delivery Systems; Controlled Drug Delivery Systems; Modulated Drug Delivery Systems
• 3) By Route: Oral Drug Delivery Systems; Injectable Drug Delivery Systems; Pulmonary Drug Delivery Systems; Transdermal Drug Delivery Systems; Other Routes
• 4) By Therapeutic Area: Cancer; Cardiovascular Diseases; Neurological Disorders; Infectious Diseases; Autoimmune Diseases
• 5) By End-User: Hospital; Specialty Clinics; Research Centers; Other End-Users
• Subsegments:
• 1) By Liposomes: PEGylated Liposomes; Cationic Liposomes; Stealth Liposomes; Immunoliposomes
• 2) By Nanoparticles: Polymeric Nanoparticles; Lipid Nanoparticles; Metallic Nanoparticles; Nanocrystals
• 3) By Microspheres: Biodegradable Microspheres; Magnetic Microspheres; Radioactive Microspheres; Mucoadhesive Microspheres
• 4) By Hydrogels: Thermosensitive Hydrogels; Ph-Responsive Hydrogels; Injectable Hydrogels; Smart Hydrogels
• 5) By Dendrimers: PAMAM Dendrimers; PPI Dendrimers; Pegylated Dendrimers; Hybrid Dendrimers
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; F. Hoffmann-La Roche AG; Merck & Co. Inc.; AbbVie Inc.; Bayer AG; Sanofi SA; Bristol-Myers Squibb Company; Thermo Fisher Scientific Company; AstraZeneca PLC; Abbott Laboratories; Novartis AG; GlaxoSmithKline PLC (GSK); Takeda Pharmaceutical Company Limited; Eli Lilly and Company; Gilead Sciences; Amgen Inc.; Teva Pharmaceutical Industries Ltd.; Otsuka Pharmaceutical Co. Ltd.; Boston Scientific Corporation; Regeneron Pharmaceuticals; Samyang Holdings Corporation; Galen Limited.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Novel Drug Delivery Systems Market Characteristics

3. Novel Drug Delivery Systems Market Trends And Strategies

4. Novel Drug Delivery Systems Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Novel Drug Delivery Systems Growth Analysis And Strategic Analysis Framework

• 5.1. Global Novel Drug Delivery Systems PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Novel Drug Delivery Systems Market Growth Rate Analysis
• 5.4. Global Novel Drug Delivery Systems Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Novel Drug Delivery Systems Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Novel Drug Delivery Systems Total Addressable Market (TAM)

6. Novel Drug Delivery Systems Market Segmentation

• 6.1. Global Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Liposomes
• Nanoparticles
• Microspheres
• Hydrogels
• Dendrimers
• 6.2. Global Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Targeted Drug Delivery Systems
• Controlled Drug Delivery Systems
• Modulated Drug Delivery Systems
• 6.3. Global Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Drug Delivery Systems
• Injectable Drug Delivery Systems
• Pulmonary Drug Delivery Systems
• Transdermal Drug Delivery Systems
• Other Routes
• 6.4. Global Novel Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cancer
• Cardiovascular Diseases
• Neurological Disorders
• Infectious Diseases
• Autoimmune Diseases
• 6.5. Global Novel Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital
• Specialty Clinics
• Research Centers
• Other End-Users
• 6.6. Global Novel Drug Delivery Systems Market, Sub-Segmentation Of Liposomes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• PEGylated Liposomes
• Cationic Liposomes
• Stealth Liposomes
• Immunoliposomes
• 6.7. Global Novel Drug Delivery Systems Market, Sub-Segmentation Of Nanoparticles, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Polymeric Nanoparticles
• Lipid Nanoparticles
• Metallic Nanoparticles
• Nanocrystals
• 6.8. Global Novel Drug Delivery Systems Market, Sub-Segmentation Of Microspheres, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Biodegradable Microspheres
• Magnetic Microspheres
• Radioactive Microspheres
• Mucoadhesive Microspheres
• 6.9. Global Novel Drug Delivery Systems Market, Sub-Segmentation Of Hydrogels, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Thermosensitive Hydrogels
• Ph-Responsive Hydrogels
• Injectable Hydrogels
• Smart Hydrogels
• 6.10. Global Novel Drug Delivery Systems Market, Sub-Segmentation Of Dendrimers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• PAMAM Dendrimers
• PPI Dendrimers
• Pegylated Dendrimers
• Hybrid Dendrimers

7. Novel Drug Delivery Systems Market Regional And Country Analysis

• 7.1. Global Novel Drug Delivery Systems Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Novel Drug Delivery Systems Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Novel Drug Delivery Systems Market

• 8.1. Asia-Pacific Novel Drug Delivery Systems Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Novel Drug Delivery Systems Market

• 9.1. China Novel Drug Delivery Systems Market Overview
• 9.2. China Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Novel Drug Delivery Systems Market

• 10.1. India Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Novel Drug Delivery Systems Market

• 11.1. Japan Novel Drug Delivery Systems Market Overview
• 11.2. Japan Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Novel Drug Delivery Systems Market

• 12.1. Australia Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Novel Drug Delivery Systems Market

• 13.1. Indonesia Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Novel Drug Delivery Systems Market

• 14.1. South Korea Novel Drug Delivery Systems Market Overview
• 14.2. South Korea Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Novel Drug Delivery Systems Market

• 15.1. Western Europe Novel Drug Delivery Systems Market Overview
• 15.2. Western Europe Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Novel Drug Delivery Systems Market

• 16.1. UK Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Novel Drug Delivery Systems Market

• 17.1. Germany Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Novel Drug Delivery Systems Market

• 18.1. France Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Novel Drug Delivery Systems Market

• 19.1. Italy Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Novel Drug Delivery Systems Market

• 20.1. Spain Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Novel Drug Delivery Systems Market

• 21.1. Eastern Europe Novel Drug Delivery Systems Market Overview
• 21.2. Eastern Europe Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Novel Drug Delivery Systems Market

• 22.1. Russia Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Novel Drug Delivery Systems Market

• 23.1. North America Novel Drug Delivery Systems Market Overview
• 23.2. North America Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Novel Drug Delivery Systems Market

• 24.1. USA Novel Drug Delivery Systems Market Overview
• 24.2. USA Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Novel Drug Delivery Systems Market

• 25.1. Canada Novel Drug Delivery Systems Market Overview
• 25.2. Canada Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Novel Drug Delivery Systems Market

• 26.1. South America Novel Drug Delivery Systems Market Overview
• 26.2. South America Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Novel Drug Delivery Systems Market

• 27.1. Brazil Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Novel Drug Delivery Systems Market

• 28.1. Middle East Novel Drug Delivery Systems Market Overview
• 28.2. Middle East Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Novel Drug Delivery Systems Market

• 29.1. Africa Novel Drug Delivery Systems Market Overview
• 29.2. Africa Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Novel Drug Delivery Systems Market Competitive Landscape And Company Profiles

• 30.1. Novel Drug Delivery Systems Market Competitive Landscape
• 30.2. Novel Drug Delivery Systems Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Novel Drug Delivery Systems Market Other Major And Innovative Companies

• 31.1. Bayer AG
• 31.2. Sanofi SA
• 31.3. Bristol-Myers Squibb Company
• 31.4. Thermo Fisher Scientific Company
• 31.5. AstraZeneca PLC
• 31.6. Abbott Laboratories
• 31.7. Novartis AG
• 31.8. GlaxoSmithKline PLC (GSK)
• 31.9. Takeda Pharmaceutical Company Limited
• 31.10. Eli Lilly and Company
• 31.11. Gilead Sciences
• 31.12. Amgen Inc.
• 31.13. Teva Pharmaceutical Industries Ltd.
• 31.14. Otsuka Pharmaceutical Co. Ltd.
• 31.15. Boston Scientific Corporation

32. Global Novel Drug Delivery Systems Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Novel Drug Delivery Systems Market

34. Recent Developments In The Novel Drug Delivery Systems Market

35. Novel Drug Delivery Systems Market High Potential Countries, Segments and Strategies

• 35.1 Novel Drug Delivery Systems Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Novel Drug Delivery Systems Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Novel Drug Delivery Systems Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer